PRESS RELEASE published on 03/13/2023 at 08:05, 2 years ago Gama Confirms Lithium Mineralization in Spodumene at CM-1 Pegmatite
PRESS RELEASE published on 03/06/2023 at 13:45, 2 years 1 month ago Gama Commences Trading on the OTCQB(R) Venture Market in the United States
PRESS RELEASE published on 03/03/2023 at 22:30, 2 years 1 month ago Gama Acquires Additional Land Holdings in the Havre St. Pierre Anorthosite Complex in Quebec and Announces Investor Relations Agreements
PRESS RELEASE published on 02/13/2023 at 14:00, 2 years 1 month ago Gama Identifies Over 30 New Potential Lithium Pegmatites on Muskox Lithium Project Using Remote Sensing Data
PRESS RELEASE published on 02/07/2023 at 22:55, 2 years 1 month ago Gama Announces Closing of Oversubscribed Private Placement
PRESS RELEASE published on 01/19/2023 at 22:35, 2 years 2 months ago Gama Provides Corporate Update on Closing of Muskox Acquisition and Financing Plans
PRESS RELEASE published on 01/16/2023 at 13:35, 2 years 2 months ago Gama Announces Acquisition of Spodumene-Bearing Muskox Pegmatite Lithium Project in Northwest Territories
PRESS RELEASE published on 01/10/2023 at 09:15, 2 years 2 months ago Gama Explorations Releases 2023 Management Update
Published on 04/07/2025 at 14:00, 12 minutes ago NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project
Published on 04/07/2025 at 14:00, 12 minutes ago Rio Grande Resources Announces the Successful Completion of Sampling and Field Campaign at the Winston Gold-Silver Project
Published on 04/07/2025 at 14:00, 12 minutes ago Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology
Published on 04/07/2025 at 14:00, 12 minutes ago GPOX Reports Record Quarterly Revenue with Significantly Improved Gross Margins
Published on 04/07/2025 at 13:00, 1 hour 12 minutes ago CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
Published on 04/07/2025 at 12:57, 1 hour 15 minutes ago PFISTERER acquires long-standing partner Power CSL - portfolio expanded to include subsea solutions
Published on 04/07/2025 at 11:57, 2 hours 14 minutes ago Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014
Published on 04/07/2025 at 11:44, 2 hours 27 minutes ago EQS-Adhoc: Rubean AG: Change in the Supervisory Board
Published on 04/07/2025 at 10:30, 3 hours 41 minutes ago Original-Research: UmweltBank AG (von GBC AG): Buy
Published on 04/07/2025 at 07:01, 7 hours 11 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 18 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 18:17, 2 days 19 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
Published on 04/04/2025 at 18:13, 2 days 19 hours ago Total number of voting rights and shares making up the share capital at March 31, 2025
